LOS ANGELES (CBSLA) – Samantha Mottet doesn’t remember much of the weeks she fought with KOVID-19.
Samantha Mottet notes Leronlimab for her Covid-19 recovery.
I was so tired that I fell asleep without realizing how sick I was, she said. I literally slept the whole time.
A 55-year-old patient from Sill Beach reported that her symptoms began to appear around mid-March, when she stopped eating and drinking and her temperature rose. Just over a week after the positive test result, she was enrolled at the University of California Medical School in Los Angeles.
My husband told me I had vomited and had diarrhoea, and I didn’t even know it, Mottet said. The whole week’s been a little blurry for me.
Mottet was on a ventilator in intensive care, where doctors tried two treatments that didn’t work. His doctor and family then contacted Dr. Otto Young, a professor of medicine at the University of California’s David Geffen School of Medicine, who is conducting a clinical trial on a drug called Leronlimab.
WARREN: WARREN: WARREN: WARREN: WARREN: WARREN: WARREN: WARREN: WARREN: WARREN: WARREN: On Friday, testing of the new Covid-19 antibody pilot will begin throughout Los Angeles County.
Researchers are injecting the drug into COVID-19 patients across the country as a potential new treatment, and Yang has offered Mottet a place in his study.
Yang said that Leronlimab is an artifact antibody that works against the second phase of Covid-19. This happens when the body’s immune system reacts too strongly to the virus. It’s injected subcutaneously.
This reaction causes a lot of collateral damage, so an inflammation of the lungs that prevents people from breathing is that collateral damage, Young said. So the idea is that it reduces inflammation in the lungs.
At this stage, doctors cannot be sure that Leronlimab is the only one responsible for the moth’s recovery. However, Yang stated that he thought there was strong evidence to support this theory.
After 24 hours she needed less oxygen on the fans and 48 hours later she could get off the fan, Yang said. Then, a few days later, she didn’t need any oxygen at all.
Leronlimab is currently undergoing FDA approval for the treatment of HIV. Researchers hope it will soon prove useful in the fight against the coronavirus.
Mottet thinks Leronlimab is the reason she’s coming home from the hospital today.
That coronavirus really knocked me out, she says. But I think the drug helped bring me back.